Dataset: Gene expression profiles of CD4+CD25+ Tregs from NOD and B6.H2g7 mice
The NOD (nonobese diabetic) mouse strain develops a characteristic autoimmune syndrome that closely resembles human type I diabetes. It...
The NOD (nonobese diabetic) mouse strain develops a characteristic autoimmune syndrome that closely resembles human type I diabetes. It has been suggested that NOD mice exhibit both numerical deficiency in CD4+CD25+ regulatory T cells (Treg) and reduced suppressive activity. We compared sorted CD4+CD25+ Tregs from the spleens of 6-7 week-old female NOD and nondiabetic B6.H2g7 mice. Tregs were 93±2% and 95±1% Foxp3+ in NOD and B6.H2g7 cells, respectively, on post-sort reanalysis. "Conventional" CD4+CD25- T cells (Tconv) are included as reference populations. Surprisingly, Treg "signature" is similar between the two strains, with only a few probesets that subtly deviate. Keywords: Cell population comparison from two mouse strains. For each strain (NOD and B6.g7), we analyzed two populations: CD4+CD25+ Treg and CD4+CD25- Tconv cells, for a total of four distinct populations. RNA from three mice were pooled for each replicate; there are three independent replicates for each population. After RMA normalization, intensity values were averaged across the three replicates and analyzed. We calculated the ratio of Treg/Tconv intensity values for each strain and compared the results.
- Species:
- mouse
- Samples:
- 12
- Source:
- E-GEOD-6813
- PubMed:
- 19073938
- Updated:
- Dec.12, 2014
- Registered:
- Nov.13, 2014
Sample | %FOXP3+ AFTER RESTAINING | SORTING | GENETIC BACKGROUND |
---|---|---|---|
GSM155600 | not specified | MACS for CD25- cells, then double-sorted for CD8a-CD11b-CD69-B220- CD4+CD25- cells | B6 congenic for MHC Class II Ag7 (H2g7) |
GSM155600 | not specified | MACS for CD25- cells, then double-sorted for CD8a-CD11b-CD69-B220- CD4+CD25- cells | B6 congenic for MHC Class II Ag7 (H2g7) |
GSM155600 | not specified | MACS for CD25- cells, then double-sorted for CD8a-CD11b-CD69-B220- CD4+CD25- cells | B6 congenic for MHC Class II Ag7 (H2g7) |
GSM155634 | not specified | MACS for CD25- cells, then double-sorted for CD8a-CD11b-CD69-B220- CD4+CD25- cells | NOD |
GSM155634 | not specified | MACS for CD25- cells, then double-sorted for CD8a-CD11b-CD69-B220- CD4+CD25- cells | NOD |
GSM155634 | not specified | MACS for CD25- cells, then double-sorted for CD8a-CD11b-CD69-B220- CD4+CD25- cells | NOD |
GSM155637 | 94% | MACS for CD25+ cells, then double-sorted for CD8a-CD11b-CD69-B220- CD4+CD25hi cells | B6 congenic for MHC Class II Ag7 (H2g7) |
GSM155638 | 96% | MACS for CD25+ cells, then double-sorted for CD8a-CD11b-CD69-B220- CD4+CD25hi cells | B6 congenic for MHC Class II Ag7 (H2g7) |
GSM155638 | 96% | MACS for CD25+ cells, then double-sorted for CD8a-CD11b-CD69-B220- CD4+CD25hi cells | B6 congenic for MHC Class II Ag7 (H2g7) |
GSM155640 | 89% | MACS for CD25+ cells, then double-sorted for CD8a-CD11b-CD69-B220- CD4+CD25hi cells | NOD |
GSM15564 | 95% | MACS for CD25+ cells, then double-sorted for CD8a-CD11b-CD69-B220- CD4+CD25hi cells | NOD |
GSM15564 | 95% | MACS for CD25+ cells, then double-sorted for CD8a-CD11b-CD69-B220- CD4+CD25hi cells | NOD |